Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K)
Overview
Plain-Language Overview
Reactive Arthritis (Reiter Syndrome) is a condition that affects the joints, usually after an infection in another part of the body, such as the urinary tract or genitals. It mainly causes joint pain and swelling, often in the knees, ankles, or feet. People may also experience symptoms in the eyes, such as redness and irritation, and problems with the urinary system. This condition is triggered by an infection with the bacterium Chlamydia trachomatis D-K, which causes a delayed immune response. The symptoms can vary in severity and may last for weeks to months, sometimes becoming chronic. It primarily impacts the musculoskeletal system but can involve multiple body systems.
Clinical Definition
Reactive Arthritis (Reiter Syndrome) is a form of seronegative spondyloarthropathy characterized by an aseptic inflammatory arthritis that develops after a genitourinary or gastrointestinal infection, most commonly due to Chlamydia trachomatis serovars D-K. The pathogenesis involves an aberrant immune response triggered by bacterial antigens, leading to inflammation in the synovium, entheses, and extra-articular sites. It typically presents with a triad of arthritis, conjunctivitis, and urethritis, although not all features are always present. The condition is strongly associated with the HLA-B27 allele, which predisposes to more severe or chronic disease. Diagnosis is clinical, supported by evidence of recent infection and exclusion of other causes. The syndrome is significant due to its potential for chronic joint damage and systemic involvement.
Inciting Event
Urogenital infection with Chlamydia trachomatis serovars D-K is the classic trigger.
Asymptomatic or symptomatic chlamydial urethritis or cervicitis precedes arthritis onset.
Other triggering infections include gastrointestinal pathogens, but Chlamydia is most common in Reiter syndrome.
Latency Period
Symptoms typically develop 1 to 4 weeks after initial chlamydial infection.
Latency allows for immune sensitization and development of reactive arthritis.
Delayed symptom onset can complicate linking arthritis to prior infection.
Diagnostic Delay
Initial arthritis symptoms may be attributed to trauma or mechanical causes.
Lack of awareness of prior asymptomatic chlamydial infection delays diagnosis.
Overlap with other spondyloarthropathies leads to misdiagnosis.
Limited use of nucleic acid amplification tests (NAATs) for Chlamydia in joint or urine samples.
Clinical Presentation
Signs & Symptoms
Asymmetric joint pain and swelling mainly in knees, ankles, and feet
Conjunctivitis causing eye redness and irritation
Urethritis with dysuria and mucopurulent discharge in men
Enthesitis presenting as localized tendon pain
Mucocutaneous manifestations such as oral ulcers and hyperkeratotic skin lesions
Constitutional symptoms including low-grade fever and malaise
History of Present Illness
Patient reports acute onset of asymmetric oligoarthritis, often involving lower limb joints such as knees and ankles.
Concurrent or preceding dysuria, urethral discharge, or cervicitis is common.
Symptoms of conjunctivitis or uveitis may accompany joint complaints.
Patients often describe enthesitis and lower back pain.
Systemic symptoms like fever and malaise may be present but are mild.
Past Medical History
History of sexually transmitted infections, especially Chlamydia trachomatis.
Previous episodes of reactive arthritis or other spondyloarthropathies.
No specific chronic illnesses directly affect risk but immunosuppression may alter presentation.
Family History
Family members with ankylosing spondylitis or other HLA-B27 associated diseases increase suspicion.
No direct hereditary pattern for reactive arthritis, but HLA-B27 inheritance is relevant.
Family history of autoimmune or inflammatory arthritis may be reported.
Physical Exam Findings
Asymmetric oligoarthritis predominantly affecting the lower extremities such as knees and ankles
Enthesitis at tendon insertions, especially the Achilles tendon and plantar fascia
Conjunctivitis or uveitis with eye redness and pain
Mucocutaneous lesions including painless oral ulcers and keratoderma blennorrhagicum on palms and soles
Dactylitis causing sausage-shaped digits
Diagnostic Workup
Diagnostic Criteria
Diagnosis of reactive arthritis is based on the presence of asymmetric oligoarthritis, typically involving the lower limbs, following a recent genitourinary infection with Chlamydia trachomatis D-K. Key diagnostic findings include evidence of urethritis or cervicitis, conjunctivitis or uveitis, and exclusion of other causes of arthritis. Laboratory tests may show elevated inflammatory markers and positive nucleic acid amplification tests (NAAT) for Chlamydia trachomatis. The presence of HLA-B27 supports the diagnosis but is not required. Synovial fluid analysis typically reveals sterile inflammation without infection.
Pathophysiology
Key Mechanisms
Autoimmune reaction triggered by molecular mimicry between Chlamydia trachomatis antigens and host tissues leads to inflammatory arthritis.
HLA-B27 positivity enhances susceptibility by promoting aberrant immune responses and chronic inflammation.
Immune complex deposition in joints and entheses causes local tissue damage and synovitis.
T-cell mediated inflammation targets synovial membranes and extra-articular sites such as the eyes and urethra.
| Involvement | Details |
|---|---|
| Organs | Joints are the main organs affected, presenting with asymmetric oligoarthritis. |
Eyes are involved in conjunctivitis or uveitis, contributing to ocular symptoms. | |
Urethra is the initial site of Chlamydia trachomatis infection triggering the reactive arthritis. | |
| Tissues | Synovial membrane is the primary site of inflammation causing arthritis and joint effusions. |
Entheses are frequently involved, leading to enthesitis and characteristic pain. | |
Conjunctival tissue may be inflamed causing conjunctivitis as part of the classic triad. | |
| Cells | CD4+ T cells mediate the autoimmune inflammatory response triggered by Chlamydia trachomatis antigens. |
Macrophages contribute to synovial inflammation by releasing proinflammatory cytokines. | |
Neutrophils infiltrate affected joints causing acute inflammation and tissue damage. | |
| Chemical Mediators | Tumor necrosis factor-alpha (TNF-α) is a key proinflammatory cytokine driving synovitis and systemic symptoms. |
Interleukin-17 (IL-17) promotes neutrophil recruitment and sustains chronic joint inflammation. | |
Prostaglandins mediate pain and swelling in affected joints. |
Treatments
Pharmacological Treatments
NSAIDs
- Mechanism:
Inhibit cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation
- Side effects:
Gastrointestinal bleeding
Renal impairment
Cardiovascular risk
- Clinical role:
First-line
Sulfasalazine
- Mechanism:
Modulates immune response by inhibiting inflammatory mediators and cytokines
- Side effects:
Rash
Leukopenia
Hepatotoxicity
- Clinical role:
Second-line
Corticosteroids
- Mechanism:
Suppresses multiple inflammatory pathways by inhibiting cytokine production and immune cell activation
- Side effects:
Hyperglycemia
Osteoporosis
Immunosuppression
- Clinical role:
Adjunctive
Antibiotics (e.g., Doxycycline)
- Mechanism:
Eradicates underlying Chlamydia trachomatis infection to reduce antigenic stimulus
- Side effects:
Photosensitivity
Gastrointestinal upset
Yeast infections
- Clinical role:
Supportive
Non-pharmacological Treatments
Physical therapy to maintain joint mobility and reduce stiffness.
Patient education on disease course and importance of adherence to therapy.
Use of assistive devices to support affected joints during acute flares.
Prevention
Pharmacological Prevention
Early antibiotic treatment targeting Chlamydia trachomatis to reduce infection burden
Use of NSAIDs to prevent or reduce inflammatory joint damage
Disease-modifying antirheumatic drugs (DMARDs) in persistent or severe arthritis
Topical or systemic corticosteroids for uveitis prevention
Non-pharmacological Prevention
Safe sexual practices including condom use to prevent Chlamydia trachomatis infection
Prompt treatment and screening of sexual partners to reduce reinfection risk
Regular ophthalmologic screening for early detection of uveitis
Physical therapy to maintain joint function and prevent stiffness
Outcome & Complications
Complications
Chronic joint damage leading to deformities and functional impairment
Vision loss from untreated or recurrent uveitis
Secondary infections due to mucocutaneous lesions or immunosuppressive therapy
Chronic urethral strictures from persistent urethritis
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) versus Psoriatic Arthritis
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) | Psoriatic Arthritis |
|---|---|
Conjunctivitis and urethritis without psoriatic skin lesions | Chronic psoriatic plaques with silvery scale often precede arthritis |
Asymmetric oligoarthritis primarily affecting large weight-bearing joints | Asymmetric oligoarthritis often involving distal interphalangeal joints |
Strong association with HLA-B27 | Strong association with HLA-Cw6 |
Nail changes uncommon | Common nail pitting and onycholysis |
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) versus Ankylosing Spondylitis
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) | Ankylosing Spondylitis |
|---|---|
Peripheral arthritis with minimal or no axial skeleton involvement | Chronic inflammatory back pain with sacroiliitis and syndesmophytes |
Usually occurs in young adults after a genitourinary or gastrointestinal infection | Typically begins in late adolescence or early adulthood (15-30 years) |
Urethritis and conjunctivitis common, uveitis less frequent | Uveitis common but urethritis rare |
Normal sacroiliac joints, no bamboo spine | Bilateral sacroiliitis and bamboo spine on X-ray |
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) versus Gonococcal Arthritis
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) | Gonococcal Arthritis |
|---|---|
Infection with Chlamydia trachomatis confirmed by nucleic acid amplification | Infection with Neisseria gonorrhoeae confirmed by culture or nucleic acid amplification |
Sterile inflammatory arthritis with conjunctivitis and urethritis | Purulent arthritis with fever and chills, often with tenosynovitis |
Inflammatory synovial fluid with negative cultures | Purulent synovial fluid with positive Gram stain and culture |
Requires antibiotics targeting Chlamydia plus NSAIDs for arthritis | Rapid improvement with intravenous ceftriaxone |
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) versus Systemic Lupus Erythematosus (SLE)
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) | Systemic Lupus Erythematosus (SLE) |
|---|---|
Negative ANA, diagnosis supported by clinical triad and infection history | Positive ANA, anti-dsDNA, and anti-Smith antibodies |
Asymmetric oligoarthritis often with enthesitis | Symmetric polyarthritis without erosions |
Primarily arthritis, urethritis, and conjunctivitis without systemic organ damage | Multisystem involvement including renal, hematologic, and neurologic manifestations |
Normal complement levels | Low complement levels during active disease |
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) versus Lyme Arthritis
Reactive Arthritis (Reiter Syndrome) (Chlamydia trachomatis D-K) | Lyme Arthritis |
|---|---|
History of recent genitourinary infection with Chlamydia trachomatis | History of tick bite or residence in endemic area |
Oligoarthritis with involvement of multiple joints including knees and ankles | Large joint monoarthritis, especially knee |
Negative Lyme serology, positive Chlamydia nucleic acid test | Positive ELISA and Western blot for Borrelia burgdorferi antibodies |
Requires antibiotics effective against Chlamydia and NSAIDs | Improves with prolonged oral doxycycline or IV ceftriaxone |